Felis consequat magnis est fames sagittis ultrices placerat sodales porttitor quisque.
In barely a decade, China has transformed from a maker of cheap generic copies of Western medicines into a global powerhouse of pharmaceutical innovation.
The country now only trails the United States in novel drugs under development, with a 29 per cent share, according to McKinsey. International pharmaceutical companies are beating a path to China’s shores to license next-generation treatments for cancer, autoimmune diseases and other disorders.
Government support, including regulatory and…
Media365Indian stock markets surged in early trade on Monday, with the Sensex gaining more than 1,100 points and the Nifty nearing 24,000, as a reported US-Iran peace breakthrough triggered a…
Media365Fintech unicorn Razorpay has confidentially filed draft IPO papers with SEBI, paving the way for a public listing that could raise between $500 million and $600 million Fintech unicorn Razorpay…
